OXYGENTA PHARMACEUTICAL
|
Last 5 Year ShareHolding (%) History of OXYGENTA PHARMACEUTICAL
Last 8 QuartersDec2024 | Sep2024 | Jun2024 | Mar2024 | Dec2023 | Sep2023 | Jun2023 | Mar2023 | ||
---|---|---|---|---|---|---|---|---|---|
Promoter and Promoter Group | |||||||||
Indian Promoters | 51.12 % | 53.28 % | 33.69 % | 29.73 % | 29.73 % | 29.73 % | 26.80 % | 8.99 % | |
Individuals / Hindu Undivided Family | 50.58 % | 52.72 % | 33.12 % | 29.73 % | 29.73 % | 29.73 % | 26.80 % | 8.99 % | |
Central Government/State Government(s) | - | - | - | - | - | - | - | - | |
Bodies Corporate | - | - | - | - | - | - | - | - | |
Financial Institutions / Banks | - | - | - | - | - | - | - | - | |
Partnership Firms | - | - | - | - | - | - | - | - | |
Promoter Group | - | - | - | - | - | - | - | - | |
Employees Welfare Fund | - | - | - | - | - | - | - | - | |
Other | 0.54 % | 0.56 % | 0.56 % | - | - | - | - | - | |
Any Others (Specify) | - | - | - | - | - | - | - | - | |
Foreign Promoters | - | - | - | - | - | - | - | - | |
Non-Residents Individuals / Foreign Individuals | - | - | - | - | - | - | - | - | |
'Bodies Corporate | - | - | - | - | - | - | - | - | |
Institutions | - | - | - | - | - | - | - | - | |
Other | - | - | - | - | - | - | - | - | |
Any Others (Specify) | - | - | - | - | - | - | - | - | |
Total of Promoter and Promoter Group | 51.12 % | 53.28 % | 33.69 % | 29.73 % | 29.73 % | 29.73 % | 26.80 % | 8.99 % | |
Pledged Promoter Holdings | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | |
Public Shareholding | |||||||||
Institutions | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.07 % | |
Mutual Funds / UTI | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.07 % | |
Financial Institutions / Banks | - | - | - | - | - | - | - | - | |
Insurance Companies | - | - | - | - | - | - | - | - | |
Foreign Institutional Investors | - | - | - | - | - | - | - | - | |
Venture Capital Funds | - | - | - | - | - | - | - | - | |
Foreign Venture Capital Investors | - | - | - | - | - | - | - | - | |
Alternate Investment Funds | - | - | - | - | - | - | - | - | |
Foreign Portfolio investors | - | - | - | - | - | - | - | - | |
 Provident funds / Pension funds | - | - | - | - | - | - | - | - | |
Multilateral & Bileteral Development Financial Institution | - | - | - | - | - | - | - | - | |
Any Others (Specify) | - | - | - | - | - | - | - | - | |
Central Government / State Government(s) | - | - | - | - | - | - | - | - | |
Foreign Financial Institutions / Banks | - | - | - | - | - | - | - | - | |
Stressed Assets Stabilisation Fund | - | - | - | - | - | - | - | - | |
Foreign Financial Institutions | - | - | - | - | - | - | - | - | |
State Finance Corporation | - | - | - | - | - | - | - | - | |
Foreign Bodies DR | - | - | - | - | - | - | - | - | |
Other | - | - | - | - | - | - | - | - | |
Non-Institutions | 48.85 % | 46.69 % | 66.29 % | 70.25 % | 70.25 % | 70.25 % | 73.18 % | 90.94 % | |
Bodies Corporate | 0.31 % | 0.34 % | 11.43 % | 12.12 % | 12.28 % | 11.82 % | 10.92 % | 25.76 % | |
Individuals | - | - | - | - | - | - | - | - | |
Individual shareholders holding nominal share capital up to Rs. 1 lakh | 7.77 % | 8.63 % | 8.13 % | 8.56 % | 7.73 % | 7.69 % | 7.87 % | 18.67 % | |
Individual shareholders holding nominal share capital in excess of Rs. 1 lakh | 36.15 % | 33.18 % | 42.18 % | 44.75 % | 45.44 % | 45.96 % | 49.18 % | 34.23 % | |
NBFCs Registed with RBI | - | - | - | - | - | - | - | - | |
Employee Trusts | - | - | - | - | - | - | - | - | |
Any Others (Specify) | - | - | 0.01 % | - | - | - | 0.01 % | - | |
Clearing Members | 0.01 % | 0.01 % | 0.01 % | - | - | - | - | 0.03 % | |
Non Resident Indians | 4.60 % | 4.53 % | 4.53 % | 4.80 % | 4.78 % | 4.76 % | 5.20 % | 12.26 % | |
Directors & their Relatives & Friends | - | - | - | - | - | - | - | - | |
Foreign Collaborators | - | - | - | - | - | - | - | - | |
Foreign Mutual Fund | - | - | - | - | - | - | - | - | |
Trusts | - | - | - | - | - | - | - | - | |
Hindu Undivided Families | - | - | - | - | - | - | - | - | |
Foreign Corporate Bodies | - | - | - | - | - | - | - | - | |
Shares in transit | - | - | - | - | - | - | - | - | |
Market Maker | - | - | - | - | - | - | - | - | |
ESOP/ESOS/ESPS | - | - | - | - | - | - | - | - | |
Societies | - | - | - | - | - | - | - | - | |
Escrow Account | - | - | - | - | - | - | - | - | |
Any Other | - | - | - | 0.01 % | 0.01 % | 0.01 % | 0.01 % | - | |
Total Public Shareholding | 48.88 % | 46.72 % | 66.31 % | 70.27 % | 70.27 % | 70.27 % | 73.20 % | 91.01 % | |
- | - | - | - | - | - | - | - | ||
Total of Promoter and Public Shareholding | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % | 100.00 % |
Compare ShareHolding of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹289.3 Cr | -1% | 1% | 95.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -1% |
1% |
95.1% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses